Recent evidence also showed that performance on a computerized version of the FNAME was associated with cerebrospinal fluid levels of amyloid, phosphorylated tau, and total tau in clinically normal and mild cognitive impairment (MCI) [11]. The gene discussed is MAPT; the disease is Cognitive impairment.